Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

A Pilot Study to Investigate the Balance between Proteases and ╬▒1-Antitrypsin in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients.

Cagnone M, Piloni D, Ferrarotti I, Di Venere M, Viglio S, Magni S, Bardoni A, Salvini R, Fumagalli M, Iadarola P, Martinello S, Meloni F.

High Throughput. 2019 Feb 13;8(1). pii: E5. doi: 10.3390/ht8010005.

2.

Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients.

Piloni D, Morosini M, Magni S, Balderacchi A, Scudeller L, Cova E, Oggionni T, Stella G, Tinelli C, Antonacci F, D'Armini AM, Meloni F.

BMC Pulm Med. 2017 Jul 18;17(1):102. doi: 10.1186/s12890-017-0446-y.

3.

Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents.

Cova E, Inghilleri S, Pandolfi L, Morosini M, Magni S, Colombo M, Piloni D, Finetti C, Ceccarelli G, Benedetti L, Cusella MG, Agozzino M, Corsi F, Allevi R, Mrakic-Sposta S, Moretti S, De Gregori S, Prosperi D, Meloni F.

Nanotoxicology. 2017 May;11(4):534-545. doi: 10.1080/17435390.2017.1317862. Epub 2017 Apr 27.

PMID:
28415888
4.

Clinical utility of CD4+ function assessment (ViraCor-IBT ImmuKnow test) in lung recipients.

Piloni D, Magni S, Oggionni T, Benazzo A, Stella G, Scudeller L, Morosini M, Cova E, Meloni F.

Transpl Immunol. 2016 Jul;37:35-39. doi: 10.1016/j.trim.2016.04.001. Epub 2016 Apr 16.

PMID:
27095000
5.

Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction.

Cova E, Colombo M, Inghilleri S, Morosini M, Miserere S, Pe├▒aranda-Avila J, Santini B, Piloni D, Magni S, Gramatica F, Prosperi D, Meloni F.

Nanomedicine (Lond). 2015 Jan;10(1):9-23. doi: 10.2217/nnm.13.208. Epub 2014 Feb 21.

PMID:
24559038

Supplemental Content

Loading ...
Support Center